These results suggest that in vivo injection of ASO-Ttbk1 successfully suppressed p-tau formation at multiple sites relevant to AD pathology in the hippocampus in PS19 mice, validating its inhibitory effect on the pre-tangle formation in early-stage AD. This evidence concerns the gene MAPT and Alzheimer disease.